The Relationship Between Upper Extremity Exercise Capacity, Respiratory and Peripheral Muscle Strength in Chronic Low Back Pain

May 28, 2025 updated by: Merve Firat, Kirsehir Ahi Evran Universitesi

The Relationship Between Upper Extremity Exercise Capacity, Respiratory and Peripheral Muscle Strength and Level of Disability in Individuals With Chronic Low Back Pain

The aim of the study was to evaluate the upper extremity exercise capacity of individuals with chronic low back pain and to investigate its relationship with respiratory muscle strength, peripheral muscle strength, chest expansion, pain, disability level, fear of movement and quality of life.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

47

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Individuals with chronic low back pain who are being followed up at the Department of Physical Medicine and Rehabilitation at Kirsehir Ahi Evran University will be included in the study.

Description

Inclusion Criteria:

  • Voluntary participation in the study
  • Being aged 18-65
  • Chronic low back pain for at least the last 3 months
  • Pain intensity according to Visual Analogue Scale (VAS) ≥3

Exclusion Criteria:

  • History of cancer
  • Presence of spinal infection
  • Presence of rheumatological disorders
  • Presence of spinal fracture
  • Red flag signs
  • Having a psychological disorder
  • Presence of spinal surgery
  • Having radiculopathy
  • Presence of anatomical and congenital abnormalities

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Indıviduals with chronic low back pain

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Respiratory muscle strength
Time Frame: 1st day
Maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) will be measured using a portable mouth pressure device.
1st day
Upper extremity exercise capacity
Time Frame: 1st day
It will be assessed by 6 minute pegboard and ring test.
1st day
Peripheral muscle strength
Time Frame: 1st day
Knee extensor, shoulder abductor and hand grip strength will be evaluated with a dynamometer.
1st day
Chest expansion
Time Frame: 1st day
Neutral, deep inspiration and deep expiration circumferences will be measured from the axillary, epigastric and subcostal regions using a tape measure.
1st day
Disability level
Time Frame: 1st day
It will be assessed with Oswestry Disability Index. High scores on the scale indicate the presence and severity of symptoms.
1st day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Kinesiophobia
Time Frame: 1st day
It will be evaluated with the Tampa Kinesiophobia scale.The total score ranges from 17-68, with a score above 37 indicating a high degree of kinesiophobia.
1st day
Quality of life
Time Frame: 1st day
It will be evaluated with the Short Form-12 Quality of Life scale.The subscales rate health from 0 to 100, with 0 indicating poor health and 100 indicating good health.
1st day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Kirsehir Ahi Evran Universitesi

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 3, 2025

Primary Completion (Estimated)

December 1, 2025

Study Completion (Estimated)

May 1, 2026

Study Registration Dates

First Submitted

February 3, 2025

First Submitted That Met QC Criteria

February 3, 2025

First Posted (Actual)

February 4, 2025

Study Record Updates

Last Update Posted (Actual)

June 2, 2025

Last Update Submitted That Met QC Criteria

May 28, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2025-02/12

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Low Back Pain

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Brazil

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe